Key result
Antifibrinolytic drugs are being evaluated to quantify their efficacy in reducing blood loss, transfusion requirements, and mortality after acute traumatic injury.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
TXA may safely reduce mortality in bleeding trauma patients; leaves open effects in isolated TBI.
BACKGROUND: Uncontrolled bleeding is an important cause of death in trauma victims.Antifibrinolytic treatment has been shown to reduce blood loss following surgery and may also be effective in reducing blood loss following trauma.OBJECTIVE: To quantify the effect of antifibrinolytic drugs in reducing blood loss, transfusion requirement and mortality after acute traumatic injury.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2011) studied this question. Antifibrinolytic drugs are being evaluated to quantify their efficacy in reducing blood loss, transfusion requirements, and mortality after acute traumatic injury.
Synapse has enriched 10 related papers. Consider them for comparative context: